The 2012 Chambers USA® Guide to America’s Leading Lawyers for Business states: “Beth Rose ‘is a litigator with impressive experience and skills,’ with sources singling her out as ‘brilliant on the regulatory side of product liability cases.’ Commentators also appreciate that she ‘is a very good team player’ and value her ‘excellent attention to detail.’”
Beth S. Rose is nationally known for her defense of pharmaceutical and medical device companies in complex product liability and mass tort litigation. She is the lawyer to whom General Counsel turn when they need an aggressive but practical approach to “bet the company” product liability matters. Clients rely on her expertise to develop successful and cost-effective strategies consistent with their business goals. Through her efforts, clients have obtained dismissals and prevailed at trial.
Ms. Rose developed her expertise in product liability matters in the late 1980s when she successfully defended a medical device manufacturer in a number of AIDS needle stick and AIDS phobia claims. She has served as national counsel to several pharmaceutical and medical device companies defending mass tort litigation including claims relating to PPA, latex gloves and a generic form of Accutane. She also led the defense of a contract research organization defending claims against a new class of antibiotics. She has successfully defended matters involving a variety of medical devices, consumer products, pharmaceuticals, foods, chemicals and industrial machines, as well as asbestos, mask respirator, silica and benzene claims.
Ms. Rose also has experience handling personal injury, consumer fraud and medical monitoring class actions. She successfully represented a pharmaceutical company in a putative nationwide class action involving an anti-arrhythmic cardiac drug. She served as co-chair of the Mass Tort Subcommittee of the ABA Litigation Section’s Class Action Committee.
Ms. Rose is Co-Chair of the Firm’s Litigation Practice Group and Chair of the Product Liability Practice Group. She was also elected to the Firm’s Management Committee.